Clinical Trials Directory

Trials / Completed

CompletedNCT01629771

Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India

Status
Completed
Phase
Study type
Observational
Enrollment
72 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

According to the World Health Organization, lymphatic filariasis, a mosquito-borne parasitic disease, is the second leading cause of disability worldwide. Across 81 countries, approximately 120 million people are infected with the disease, and of those infected, an estimated 40% reside in India alone. The most disfiguring symptoms of lymphatic filariasis, elephantiasis and lymphedema, cause long-term suffering in patients who are then often embarrassed or even rejected from their communities. Because of the disease's debilitating physical and social effects on patients, this study will explore the intersection of disability and health-related quality of life (HRQoL) in lymphatic filariasis patients in India. Specifically, HRQoL and disability in lymphatic filariasis subjects and age- and gender- matched control subjects will be compared. Two HRQoL tools , the general Dermatology Life Quality Index (DLQI) and a disease-specific instrument developed by a dermatology group in India will be used to gauge HRQol. In addition, the demographic and disease-specific factors associated with HRQoL and disability in filarial lymphedema subjects will be identified.

Conditions

Timeline

Start date
2012-05-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2012-06-28
Last updated
2014-03-20
Results posted
2013-08-02

Locations

2 sites across 2 countries: United States, India

Source: ClinicalTrials.gov record NCT01629771. Inclusion in this directory is not an endorsement.